APA (7th ed.) Citation

A, A., L, F., P, O., L, M., A, R., L, M., . . . D, B. (2025). Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models. Molecular oncology, 19(4), 1075. https://doi.org/10.1002/1878-0261.13816

Chicago Style (17th ed.) Citation

A, Anastasia, et al. "Stroma Gene Signature Predicts Responsiveness to Chemotherapy in Pancreatic Ductal Adenocarcinoma Patient-derived Xenograft Models." Molecular Oncology 19, no. 4 (2025): 1075. https://doi.org/10.1002/1878-0261.13816.

MLA (9th ed.) Citation

A, Anastasia, et al. "Stroma Gene Signature Predicts Responsiveness to Chemotherapy in Pancreatic Ductal Adenocarcinoma Patient-derived Xenograft Models." Molecular Oncology, vol. 19, no. 4, 2025, p. 1075, https://doi.org/10.1002/1878-0261.13816.